Our previous meta-analysis of YAP1 revealed that both overall and nuclear overexpression levels of YAP1 were intimately associated with adverse OS and disease-free survival (DFS) in several cancers, including CRC [26–28]. The gene discussed is YAP1; the disease is colorectal carcinoma.